Literature DB >> 8887906

Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury.

M A Clark1, B T Hentzen, L D Plank, G I Hill.   

Abstract

BACKGROUND: Our group wanted to test the hypothesis that plasma levels of insulin-like growth factor 1 (IGF-1), transferrin, and prealbumin are useful markers of nutritional progress in severe sepsis and multiple injury.
METHODS: Measurements of IGF-1 and plasma proteins were made in critically ill patients as soon as they were hemodynamically stable and 5, 10, 15, and 21 days later. The magnitude and direction of the measured changes were compared with the magnitude and direction of the change in total body protein in the same time period.
RESULTS: Fourteen patients with severe sepsis and 10 multiply injured patients were studied. As a group they had an increased metabolic expenditure that peaked at 153% of normal and lost approximately 12.0% of total body protein. An early fall in IGF-1 and plasma proteins accompanied a marked acute phase response, and recovery occurred while hypermetabolism and net proteolysis continued. No correlation existed between changes in IGF-1 or plasma proteins and the change in total body protein.
CONCLUSIONS: Plasma levels of IGF-1, transferrin, and prealbumin are not useful for following changes in protein stores early in the course of critical illness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887906     DOI: 10.1177/0148607196020005363

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  8 in total

Review 1.  Protein requirements, morbidity and mortality in critically ill patients: fundamentals and applications.

Authors:  Haroldo Falcão Ramos da Cunha; Eduardo Eiras Moreira da Rocha; Monica Hissa
Journal:  Rev Bras Ter Intensiva       Date:  2013-03

2.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

3.  Alteration of transthyretin microheterogeneity in serum of multiple trauma patients.

Authors:  Beate Gericke; Jens Raila; Maria Deja; Sascha Rohn; Bernd Donaubauer; Britta Nagl; Sophie Haebel; Florian J Schweigert; Udo Kaisers
Journal:  Biomark Insights       Date:  2007-08-08

4.  Associations of serum transthyretin with triglyceride in non-obese elderly Japanese women independently of insulin resistance, HDL cholesterol, and adiponectin.

Authors:  Satomi Minato-Inokawa; Ayaka Tsuboi; Mika Takeuchi; Kaori Kitaoka; Megumu Yano; Miki Kurata; Tsutomu Kazumi; Keisuke Fukuo
Journal:  Diabetol Int       Date:  2021-02-13

Review 5.  Nutrients and Porphyria: An Intriguing Crosstalk.

Authors:  Elena Di Pierro; Francesca Granata
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

6.  Elevated serum adiponectin and tumor necrosis factor-α and decreased transthyretin in Japanese elderly women with low grip strength and preserved muscle mass and insulin sensitivity.

Authors:  Mika Takeuchi; Ayaka Tsuboi; Satomi Minato; Megumu Yano; Kaori Kitaoka; Miki Kurata; Tsutomu Kazumi; Keisuke Fukuo
Journal:  BMJ Open Diabetes Res Care       Date:  2018-09-05

7.  Non-islet Cell Hypoglycemia: Case Series and Review of the Literature.

Authors:  Vishnu Garla; Hardik Sonani; Venkatraman Palabindala; Celso Gomez-Sanchez; Jose Subauste; Lillian Francis Lien
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-15       Impact factor: 5.555

8.  Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology.

Authors:  Elisa Diaz-Riera; Maísa García-Arguinzonis; Laura López; Xavier Garcia-Moll; Lina Badimon; Teresa Padro
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.